References
- Wang M, Sun H, Yao Y, et al. MicroRNA-217/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP+-induced SH-SY5Y cells. Am J Transl Res. 2019;11(10):6619–6631.
- Dauer W, Przedborski S. Parkinson’s disease: mechanisms and models. Neuron. 2003;39(6):889–909.
- Patel S, Singh V, Kumar A, et al. Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson’s disease phenotype in mouse: mechanism of neurodegeneration. Brain Res. 2006;1081(1):9–18.
- Skaper SD. The brain as a target for inflammatory processes and neuroprotective strategies. Ann N Y Acad Sci. 2007;1122:23–34.
- Moore DJ, West AB, Dawson VL, et al. Molecular pathophysiology of Parkinson’s disease. Annu Rev Neurosci. 2005;28:57–87.
- Ng SY, Lin L, Soh BS, et al. Long noncoding RNAs in development and disease of the central nervous system. Trends Genet. 2013;29(8):461–468.
- Kraus TFJ, Haider M, Spanner J, et al. Altered long noncoding RNA expression precedes the course of Parkinson’s disease-a preliminary report. Mol Neurobiol. 2017;54(4):2869–2877.
- Yan W, Chen ZY, Chen JQ, et al. LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson’s disease through stabilizing PINK1 protein. Biochem Biophys Res Commun. 2018;496(4):1019–1024.
- Long L, Cai X, Liao J, et al. H2s alleviates Parkinson-like phenotypes by modulating lncRNA-CasC7/miR-30c/BNIP3L signaling pathway. Arch Med Sci. 2021. DOI:10.5114/aoms/114038
- Lu Y, Gong Z, Jin X, et al. LncRNA MALAT1 targeting miR4 regulates DAPK1 expression contributes to cell apoptosis in Parkinson’s disease. J Cell Biochem. 2020;121(12):4838–4848.
- Xie N, Qi J, Li S, et al. Upregulated lncRNA small nucleolar RNA host gene 1 promotes 1-methyl-4-phenylpyridinium ion-induced cytotoxicity and reactive oxygen species production through miR-15b-5p/GSK3-β axis in human dopaminergic SH-SY5Y cells. J Cell Biochem. 2019;120(4):5790–5801.
- Wo Q, Zhang D, Hu L, et al. Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis. Biochem Biophys Res Commun. 2019;520(3):586–593.
- Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
- Li M, Marin-Muller C, Bharadwaj U, et al. MicroRNAs: control and loss of control in human physiology and disease. World J Surg. 2009;33(4):667–684.
- Nuzziello N, Craig F, Simone M, et al. Integrated analysis of microRNA and mRNA expression profiles: an attempt to disentangle the complex interaction network in attention deficit hyperactivity disorder. Brain Sci. 2019;9(10):288.
- Flower TR, Chesnokova LS, Froelich CA, et al. Heat shock prevents alpha-synuclein-induced apoptosis in a yeast model of Parkinson’s disease. J Mol Biol. 2005;351(5):1081–1100.
- Banati RB, Daniel SE, Blunt SB. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson’s disease. Mov Disord. 1998;13(2):221–227.
- Luo Q, Zhao M, Zhong J, et al. NAIF1 is down-regulated in gastric cancer and promotes apoptosis through the caspase-9 pathway in human MKN45 cells. Oncol Rep. 2011;25(4):1117–1123.
- Lv B, Shi T, Wang X, et al. Overexpression of the novel human gene, nuclear apoptosis-inducing factor 1, induces apoptosis. Int J Biochem Cell Biol. 2006;38(4):671–683.
- Kong D, Zhang Z. NAIF1 suppresses osteosarcoma progression and is regulated by miR-128. Cell Biochem Funct. 2018;36(8):443–449.
- Zhang L, Kang W, Lu X, et al. LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway. Cell Cycle. 2018;17:1886–1900.
- Geng L, Zhang T, Liu W, et al. miR-494-3p modulates the progression of in vitro and in vivo Parkinson’s disease models by targeting SIRT3. Neurosci Lett. 2018;675:23–30.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
- Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. 2018;2018:6.
- Pietkiewicz S, Schmidt JH, Lavrik IN. Quantification of apoptosis and necroptosis at the single cell level by a combination of imaging flow cytometry with classical Annexin V/propidium iodide staining. J Immunol Methods. 2015;423:99–103.
- Tam SY, Wu VWC, Law HKW, et al. Low oxygen level induced epithelial-mesenchymal transition and stemness maintenance in colorectal cancer cells. Cancers (Basel). 2020;12:1.
- Shahryari AR, Malakootian M, Shafiee. Identification A novel regulatory mechanism governing one of the key stem cell pluripotency genes, SOX2, mediated by the non-coding RNA SOX2OT. Cell J. 2013;15:77–78.
- Shahryari A, Jazi MS, Samaei NM, et al. Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis. Front Genet. 2015;6:196.
- Wu P, Zuo X, Deng H, et al. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res Bull. 2013;97:69–80.
- Ying L, Bai L, Qin C. Long noncoding RNAs in neurodevelopment and Parkinson’s disease. Animal Models Exp Med. 2019;2(4):239–251.
- Zhou Y, Gu C, Li J, et al. Aberrantly expressed long noncoding RNAs and genes in Parkinson’s disease. Neuropsychiatr Dis Treat. 2018;14:3219–3229.
- Soreq L, Guffanti A, Salomonis N, et al. Long non-coding RNA and alternative splicing modulations in Parkinson’s leukocytes identified by RNA sequencing. PLoS Comput Biol. 2014;10(3):e1003517.
- Lu X, Cui Z, Liu S, et al. MiRNAs participate in the diagnosis, pathogenesis and therapy of Parkinson’s disease. Histol Histopathol. 2018;33(5):447–453.
- Afjeh S, Ghaderian S. The role of microRNAs in cardiovascular disease. Int J Mol Cell Med. 2013;2(2):50–57.
- Ventura A, Young AG, Winslow MM, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008;132(5):875–886.
- Soreq L, Salomonis N, Bronstein M, et al. Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front Mol Neurosci. 2013;6:10.
- Lilach S, Hagai B, Zvi I, et al. MicroRNA expression changes in Parkinson’s disease (PD) patients’ leukocytes prior to and following deep brain stimulation (DBS). Am J Neurodegener Dis. 2021;10(3):28–33.
- Wu X, Hu C, Long C, et al. MicroRNA-351 promotes the proliferation and invasion of glioma cells through downregulation of NAIF1. J Mol Neurosci. 2020;70(10):1493–1499.
- Wang S, He H, Chen L, et al. Protective effects of salidroside in the MPTP/MPP+-induced model of Parkinson’s disease through ROS-NO-related mitochondrion pathway. Mol Neurobiol. 2015;51(2):718–728.
- Guo H, Ning-Ning LI, Wang GX, et al. Roles of reproductive hormone, LDH and PARP in apoptosis in spermatogenic cells of rats exposed to manganese. Anat Res. 2016;2:24–27.
- Depino AM, Earl C, Kaczmarczyk E, et al. Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson’s disease. Eur J Neurosci. 2003;18(10):2731–2742.